Der Hauptunterschied der Medikamente liegt einzig bei der Zulassung: Mounjaro ist derzeit nur zur Behandlung von Typ-2-Diabetes zugelassen, Zepbound ist in den USA spezifisch zur Behandlung von bergewicht zugelassen
Corticosteroids decrease inflammation by stabilizing leukocyte lysosomal membranes, preventing release of destructive acid hydrolases from leukocytes
A New Use for Wegovy Opens the Door to Medicare Coverage for Millions of People with Obesity The FDA recently approved a new use for Wegovy (semaglutide), the blockbuster anti-obesity drug, to reduce the risk of heart attacks and stroke in people with cardiovascular disease who are overweight or obese
May JM, Mendiratta S, Hill KE, Burk RF (1997) Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase
Clinical/demographic/medication, especially rifaximin details were recorded